Melanie Swan is a genomics researcher, hedge fund manager, and leader in the Health 2.0 movement. She is focused on translational research in emerging high-impact science areas. Recent publications include “Multigenic Condition Risk Assessment in Direct-to-Consumer Genomic Services,” “Engineering Life into Technology,” and “Emerging Patient-Driven Health Care Models.” She serves as an advisor to research foundations, government agencies, corporations, and startups. Melanie has an MBA from the Wharton School of the University of Pennsylvania and a BA from Georgetown University. She is an advisor and faculty member at Singularity University.
- MS Futures GroupGenomics research, hedge fund management, present